KLK3 and prostate cancer: The cancer detection rate for prostate cancer in 2003 was 1.48% by population-based mass screening using prostate-specific antigen (PSA) testing.18 According to the national estimates, the incidence of prostate cancer significantly increased, especially from 2000, although mortality remains unchanged (1999–2006).